{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:49:42Z","timestamp":1786981782009,"version":"build-2736575974"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T00:00:00Z","timestamp":1706400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T00:00:00Z","timestamp":1706400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Changsha Natural Science Foundation","award":["kq2007060"],"award-info":[{"award-number":["kq2007060"]}]},{"DOI":"10.13039\/501100004761","name":"Hunan province Natural Science Foundation","doi-asserted-by":"crossref","award":["2023JJ60065"],"award-info":[{"award-number":["2023JJ60065"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-023-02932-5","type":"journal-article","created":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T00:02:43Z","timestamp":1706400163000},"page":"520-530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Different drugs in drug-eluting stents for peripheral artery disease: a systematic evaluation and Bayesian meta-analysis"],"prefix":"10.1007","volume":"57","author":[{"given":"Keqin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiehong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,28]]},"reference":[{"issue":"9","key":"2932_CR1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T et al (2018) 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic Disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)the Task Force for the diagnosis and treatment of peripheral arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39(9):763\u2013816","journal-title":"Eur Heart J"},{"issue":"1","key":"2932_CR2","doi-asserted-by":"publisher","first-page":"010601","DOI":"10.7189\/jogh.09.010601","volume":"9","author":"P Song","year":"2019","unstructured":"Song P, Rudan D, Wang M, Chang X, Rudan I (2019) National and subnational estimation of the prevalence of peripheral artery Disease (PAD) in China: a systematic review and meta-analysis. J Glob Health 9(1):010601","journal-title":"J Glob Health"},{"key":"2932_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pcad.2021.11.008","volume":"69","author":"RB Parikh","year":"2021","unstructured":"Parikh RB, Victor V, Levy MS (2021) Catheter based interventions for lower extremity peripheral artery Disease. Prog Cardiovasc Dis 69:62\u201372","journal-title":"Prog Cardiovasc Dis"},{"issue":"12","key":"2932_CR4","first-page":"e686","volume":"135","author":"M Gerhard-Herman","year":"2017","unstructured":"Gerhard-Herman M, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE et al (2017) 2016 AHA\/ACC Guideline on the management of patients with Lower Extremity Peripheral Artery Disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines. Circulation 135(12):e686\u2013e725","journal-title":"Circulation"},{"issue":"3","key":"2932_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s40256-018-0265-4","volume":"18","author":"K Abdullah","year":"2018","unstructured":"Abdullah K, Bou Dargham B, Steinbrecher M, Sun B, Huiqiang Z, Khalili H et al (2018) Drug-eluting stents for treatment of Peripheral Artery Disease. Am J Cardiovasc Drugs 18(3):175\u2013180","journal-title":"Am J Cardiovasc Drugs"},{"issue":"5","key":"2932_CR6","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jvs.2008.01.005","volume":"47","author":"M Romiti","year":"2008","unstructured":"Romiti M, Albers M, Brochado-Neto FC, Durazzo A, Pereira C, Luccia ND (2008) Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 47(5):975\u2013981","journal-title":"J Vasc Surg"},{"issue":"9","key":"2932_CR7","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.jvir.2009.05.031","volume":"20","author":"D Siablis","year":"2009","unstructured":"Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Spiliopoulos S, Kagadis GC et al (2009) Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol 20(9):1141\u20131150","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"2932_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jvs.2011.07.099","volume":"55","author":"M Bosiers","year":"2012","unstructured":"Bosiers M, Scheinert D, Peeters P, Torsello G, Zeller T, Deloose K et al (2012) Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive Disease. J Vasc Surg 55(2):390\u2013398","journal-title":"J Vasc Surg"},{"issue":"1","key":"2932_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/1526602814565778","volume":"22","author":"M Truijers","year":"2015","unstructured":"Truijers M, Reijnen MMPJ (2015) Commentary: treatment of in-stent restenosis in the superficial femoral artery: at the crossroads of using either covered stents or paclitaxel-based modalities. J Endovasc Ther 22(1):11\u201313","journal-title":"J Endovasc Ther"},{"issue":"1s","key":"2932_CR10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","volume":"58","author":"MS Conte","year":"2019","unstructured":"Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R et al (2019) Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg 58(1s):S1\u2013S109e33","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"2932_CR11","first-page":"8","volume":"63","author":"GT Taneva","year":"2022","unstructured":"Taneva GT, Pitoulias GA, Abu Bakr N, Kazemtash M, Mu\u00f1oz Castellanos J, Donas KP (2022) Assessment of Sirolimus- vs. paCLitaxEl-coated balloon angioPlasty in atherosclerotic femoropopliteal lesiOnS (ASCLEPIOS Study): preliminary results. J Cardiovasc Surg (Torino) 63(1):8\u201312","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"2932_CR12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"12","key":"2932_CR13","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1161\/01.CIR.0000029746.10018.36","volume":"106","author":"SH Duda","year":"2002","unstructured":"Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A et al (2002) Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery Disease: six-month results. Circulation 106(12):1505\u20131509","journal-title":"Circulation"},{"issue":"3","key":"2932_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/01.RVI.0000151260.74519.CA","volume":"16","author":"SH Duda","year":"2005","unstructured":"Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A et al (2005) Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery Disease: the SIROCCO II trial. J Vasc Interv Radiol 16(3):331\u2013338","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"2932_CR15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1583\/05-1620MR.1","volume":"12","author":"D Siablis","year":"2005","unstructured":"Siablis D, Kraniotis P, Karnabatidis D, Kagadis GC, Katsanos K, Tsolakis J (2005) Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-Month angiographic results from a nonrandomized prospective single-center study. J Endovas Ther 12(6):685\u2013695","journal-title":"J Endovas Ther"},{"issue":"4","key":"2932_CR16","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1007\/s00330-008-1225-1","volume":"19","author":"A Falkowski","year":"2009","unstructured":"Falkowski A, Poncyljusz W, Wilk G, Szczerbo-Trojanowska M (2009) The evaluation of primary stenting of sirolimus-eluting versus bare-metal stents in the treatment of atherosclerotic lesions of crural arteries. Eur Radiol 19(4):966\u2013974","journal-title":"Eur Radiol"},{"issue":"18","key":"2932_CR17","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1093\/eurheartj\/ehr144","volume":"32","author":"A Rastan","year":"2011","unstructured":"Rastan A, Tepe G, Krankenberg H, Zahorsky R, Beschorner U, Noory E et al (2011) Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial. EUR HEART J 32(18):2274\u20132281","journal-title":"EUR HEART J"},{"issue":"24","key":"2932_CR18","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","volume":"61","author":"MD Dake","year":"2013","unstructured":"Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB et al (2013) Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol 61(24):2417\u20132427","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2932_CR19","doi-asserted-by":"publisher","first-page":"e002376","DOI":"10.1161\/CIRCINTERVENTIONS.114.002376","volume":"9","author":"MI Spreen","year":"2016","unstructured":"Spreen MI, Martens JM, Hansen BE, Knippenberg B, Verhey E, van Dijk LC et al (2016) Percutaneous transluminal angioplasty and drug-eluting stents for Infrapopliteal Lesions in critical limb ischemia (PADI) trial. Circ Cardiovasc Interv 9(2):e002376","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"2932_CR20","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00380-017-0982-7","volume":"32","author":"S Mori","year":"2017","unstructured":"Mori S, Hirano K, Yamauchi Y, Hayashi E, Doijiri T, Takamura T et al (2017) Penetration rate of the placement of a drug-eluting stent for the treatment of superficial femoral artery lesions in Japan. Heart Vessels 32(9):1093\u20131098","journal-title":"Heart Vessels"},{"key":"2932_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.avsg.2016.10.058","volume":"43","author":"PA Vent","year":"2017","unstructured":"Vent PA, Kaladji A, Davaine JM, Guyomarch B, Chaillou P, Costargent A et al (2017) Bare Metal Versus Paclitaxel-Eluting Stents for Long Femoropopliteal Lesions: Prospective Cohorts Comparison Using a Propensity Score-Matched Analysis. Ann Vasc Surg 43:166\u201375","journal-title":"Ann Vasc Surg"},{"key":"2932_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.avsg.2018.04.014","volume":"53","author":"P Bj\u00f6rkman","year":"2018","unstructured":"Bj\u00f6rkman P, Auvinen T, Hakovirta H, Romsi P, Turtiainen J, Manninen H et al (2018) Drug-Eluting Stent Shows Similar Patency Results as Prosthetic Bypass in Patients with Femoropopliteal Occlusion in a Randomized Trial. Ann Vasc Surg 53:165\u2013170","journal-title":"Ann Vasc Surg"},{"issue":"8","key":"2932_CR23","doi-asserted-by":"publisher","first-page":"e006564","DOI":"10.1161\/CIRCINTERVENTIONS.118.006564","volume":"11","author":"T Miura","year":"2018","unstructured":"Miura T, Miyashita Y, Soga Y, Hozawa K, Doijiri T, Ikeda U et al (2018) Drug-eluting Versus Bare-Metal Stent Implantation with or without Cilostazol in the treatment of the superficial femoral artery. Circ Cardiovasc Interv 11(8):e006564","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"2932_CR24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1177\/1708538119850445","volume":"27","author":"P Kibrik","year":"2019","unstructured":"Kibrik P, Victory J, Patel R, Chait J, Alsheekh A, Aurshina A et al (2019) A real-world experience of drug eluting and non-drug eluting stents in lower extremity peripheral arterial Disease. Vascular 27(6):648\u2013652","journal-title":"Vascular"},{"issue":"7","key":"2932_CR25","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.3390\/jcm9072221","volume":"9","author":"A Falkowski","year":"2020","unstructured":"Falkowski A, Bogacki H, Szemitko M (2020) Assessment of Mortality and factors affecting outcome of Use of Paclitaxel-Coated stents and Bare Metal stents in Femoropopliteal PAD. J Clin Med 9(7):2221","journal-title":"J Clin Med"},{"issue":"9","key":"2932_CR26","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s00270-021-02901-6","volume":"44","author":"O Iida","year":"2021","unstructured":"Iida O, Fujihara M, Kawasaki D, Mori S, Yokoi H, Miyamoto A et al (2021) 24-Month Efficacy and Safety results from Japanese patients in the IMPERIAL Randomized Study of the Eluvia Drug-Eluting Stent and the Zilver PTX Drug-Coated Stent. Cardiovasc Intervent Radiol 44(9):1367\u20131374","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"2932_CR27","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00270-020-02693-1","volume":"44","author":"S M\u00fcller-H\u00fclsbeck","year":"2021","unstructured":"M\u00fcller-H\u00fclsbeck S, Benko A, Soga Y, Fujihara M, Iida O, Babaev A et al (2021) Two-year efficacy and safety results from the IMPERIAL Randomized Study of the Eluvia polymer-coated drug-eluting stent and the Zilver PTX polymer-free drug-coated stent. Cardiovasc Intervent Radiol 44(3):368\u2013375","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2932_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.sopen.2021.09.004","volume":"7","author":"R Marples","year":"2022","unstructured":"Marples R, Binks M, Spina R, Wright M, Huilgol R (2022) Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency. Surg Open Science 7:18\u201321","journal-title":"Surg Open Science"},{"issue":"3","key":"2932_CR29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/1526602816639721","volume":"23","author":"Y Tomoi","year":"2016","unstructured":"Tomoi Y, Soga Y, Iida O, Shiraki T, Kobayashi Y, Hiramori S et al (2016) Impact of drug-eluting stent implantation for Femoropopliteal In-Stent occlusion. J Endovasc Ther 23(3):461\u2013467","journal-title":"J Endovasc Ther"},{"issue":"4","key":"2932_CR30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1177\/1526602817708778","volume":"24","author":"GM Ansel","year":"2017","unstructured":"Ansel GM, Jaff MR, Popma JJ, Battisti AJ, Lottes AE, Harnish P et al (2017) A Quantitative Angiographic Comparison of Restenotic Tissue Following Placement of Drug-Eluting Stents and Bare Metal stents in symptomatic patients with Femoropopliteal Disease. J Endovasc Ther 24(4):499\u2013503","journal-title":"J Endovasc Ther"},{"issue":"4","key":"2932_CR31","doi-asserted-by":"publisher","first-page":"e004877","DOI":"10.1161\/JAHA.116.004877","volume":"6","author":"MI Spreen","year":"2017","unstructured":"Spreen MI, Martens JM, Knippenberg B, van Dijk LC, de Vries JPM, Vos JA et al (2017) Long-term follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting stents for Infrapopliteal Lesions in critical limb ischemia. J Am Heart Assoc 6(4):e004877","journal-title":"J Am Heart Assoc"},{"issue":"10157","key":"2932_CR32","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0140-6736(18)32262-1","volume":"392","author":"WA Gray","year":"2018","unstructured":"Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y et al (2018) A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial. Lancet 392(10157):1541\u20131551","journal-title":"Lancet"},{"issue":"2","key":"2932_CR33","first-page":"130","volume":"34","author":"FC Meng","year":"2018","unstructured":"Meng FC, Chen PL, Lee CY, Shih CC, Chen IM (2018) Real-world comparison of drug-eluting and Bare-Metal stents in superficial femoral artery Occlusive Disease with Trans-Atlantic Intersociety Consensus B lesions: a 2-Year, single-Institute study. Acta Cardiol Sin 34(2):130\u2013136","journal-title":"Acta Cardiol Sin"},{"issue":"6","key":"2932_CR34","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.ejvs.2019.09.002","volume":"58","author":"A Haine","year":"2019","unstructured":"Haine A, Schmid MJ, Schindewolf M, Lenz A, Bernhard SM, Drexel H et al (2019) Comparison between interwoven Nitinol and Drug Eluting stents for Endovascular Treatment of Femoropopliteal Artery Disease. Eur J Vasc Endovasc Surg 58(6):865\u2013873","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"5","key":"2932_CR35","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ejvs.2019.06.012","volume":"58","author":"A Saratzis","year":"2019","unstructured":"Saratzis A, Rudarakanchana N, Patel S, Diamantopoulos A, Lea T, Corbo B et al (2019) Interwoven Nitinol stents versus Drug Eluting stents in the Femoro-Popliteal segment: a propensity matched analysis. Eur J Vasc Endovasc Surg 58(5):719\u2013727","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"2932_CR36","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jcin.2019.12.028","volume":"13","author":"Y Gou\u00ebffic","year":"2020","unstructured":"Gou\u00ebffic Y, Sauguet A, Desgranges P, Feugier P, Rosset E, Ducasse E et al (2020) A polymer-free paclitaxel-eluting Stent Versus a Bare-Metal Stent for De Novo Femoropopliteal lesions: the BATTLE trial. JACC Cardiovasc Interv 13(4):447\u2013457","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"2932_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00270-019-02355-x","volume":"43","author":"Y Soga","year":"2020","unstructured":"Soga Y, Fujihara M, Iida O, Kawasaki D, Hirano K, Yokoi H et al (2020) Japanese patients treated in the IMPERIAL Randomized Trial comparing Eluvia and Zilver PTX stents. Cardiovasc Intervent Radiol 43(2):215\u2013222","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"11","key":"2932_CR38","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1253\/circj.CJ-20-0551","volume":"84","author":"T Tsujimura","year":"2020","unstructured":"Tsujimura T, Ishihara T, Iida O, Hata Y, Kurata N, Asai M et al (2020) Angioscopic assessments at 3 months after Fluoropolymer-based paclitaxel-eluting stent implantation for Femoropopliteal Endovascular intervention. Circ J 84(11):1999\u20132005","journal-title":"Circ J"},{"key":"2932_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.avsg.2020.08.124","volume":"71","author":"N Zamani","year":"2021","unstructured":"Zamani N, Sharath SE, Browder RC, Barshes NR, Braun JD, Mills JL Sr et al (2021) Outcomes after Endovascular Stent Placement for Long-Segment superficial femoral artery lesions. Ann Vasc Surg 71:298\u2013307","journal-title":"Ann Vasc Surg"},{"issue":"6","key":"2932_CR40","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1583\/05-1704.1","volume":"13","author":"SH Duda","year":"2006","unstructured":"Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V et al (2006) Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 13(6):701\u2013710","journal-title":"J Endovasc Ther"},{"issue":"2","key":"2932_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/152660280701400217","volume":"14","author":"D Siablis","year":"2007","unstructured":"Siablis D, Karnabatidis D, Katsanos K, Kagadis GC, Kraniotis P, Diamantopoulos A et al (2007) Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther 14(2):241\u2013250","journal-title":"J Endovasc Ther"},{"issue":"2","key":"2932_CR42","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jvs.2020.05.061","volume":"73","author":"A Mathlouthi","year":"2021","unstructured":"Mathlouthi A, Yei KS, Naazie I, Bertges DJ, Malas MB (2021) Increased mortality with paclitaxel-eluting stents is driven by lesion length. J Vasc Surg 73(2):548\u201353e2","journal-title":"J Vasc Surg"},{"issue":"4","key":"2932_CR43","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.jvs.2022.09.022","volume":"77","author":"KY Fong","year":"2022","unstructured":"Fong KY, Xin L, Ng J, Loh SEK, Ng JJ, Choong A (2022) A systematic review and meta-analysis of sirolimus-eluting stents for treatment of below-the-knee arterial Disease. J Vasc Surg 77(4):1264\u20131273","journal-title":"J Vasc Surg"},{"issue":"5698","key":"2932_CR44","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/277665a0","volume":"277","author":"PB Schiff","year":"1979","unstructured":"Schiff PB, Fant J, Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277(5698):665\u2013667","journal-title":"Nature"},{"issue":"2","key":"2932_CR45","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1161\/01.CIR.96.2.636","volume":"96","author":"DI Axel","year":"1997","unstructured":"Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Kuttner A et al (1997) Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 96(2):636\u2013645","journal-title":"Circulation"},{"issue":"18","key":"2932_CR46","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1161\/01.CIR.103.18.2289","volume":"103","author":"AW Heldman","year":"2001","unstructured":"Heldman AW, Cheng L, Jenkins GM, Heller PF, Kim DW, Ware M Jr. et al (2001) Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 103(18):2289\u20132295","journal-title":"Circulation"},{"issue":"10","key":"2932_CR47","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1161\/01.STR.0000242481.38262.7b","volume":"37","author":"R Gupta","year":"2006","unstructured":"Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA et al (2006) Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 37(10):2562\u20132566","journal-title":"Stroke"},{"issue":"1","key":"2932_CR48","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ccd.27635","volume":"92","author":"DN Feldman","year":"2018","unstructured":"Feldman DN, Armstrong EJ, Aronow HD, Gigliotti OS, Jaff MR, Klein AJ et al (2018) SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions. Catheter Cardiovasc Interv 92(1):124\u2013140","journal-title":"Catheter Cardiovasc Interv"},{"issue":"15","key":"2932_CR49","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","volume":"133","author":"MD Dake","year":"2016","unstructured":"Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB et al (2016) Durable clinical effectiveness with paclitaxel-eluting stents in the Femoropopliteal artery: 5-Year results of the Zilver PTX Randomized Trial. Circulation 133(15):1472\u20131483","journal-title":"Circulation"},{"issue":"1 Pt A","key":"2932_CR50","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","volume":"8","author":"G Tepe","year":"2015","unstructured":"Tepe G, Schnorr B, Albrecht T, Brechtel K, Claussen CD, Scheller B et al (2015) Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. JACC Cardiovasc Interv 8(1 Pt A):102\u2013108","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"2932_CR51","doi-asserted-by":"publisher","first-page":"e005891","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","volume":"11","author":"PA Schneider","year":"2018","unstructured":"Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D et al (2018) Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA Randomized Trial. Circ Cardiovasc Interv 11(1):e005891","journal-title":"Circ Cardiovasc Interv"},{"issue":"5","key":"2932_CR52","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","volume":"4","author":"MD Dake","year":"2011","unstructured":"Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB et al (2011) Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal Disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 4(5):495\u2013504","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"2932_CR53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jvs.2019.05.002","volume":"70","author":"JL Mills","year":"2019","unstructured":"Mills JL, Conte MS, Murad MH (2019) Critical review and evidence implications of paclitaxel drug-eluting balloons and stents in peripheral artery Disease. J Vasc Surg 70(1):3\u20137","journal-title":"J Vasc Surg"},{"key":"2932_CR54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00392-002-1310-4","volume":"3","author":"K Toutouzas","year":"2002","unstructured":"Toutouzas K, Di Mario C, Falotico R, Takagi T, Stankovic G, Albiero R et al (2002) Sirolimus-eluting stents: a review of experimental and clinical findings. Z Kardiol 91 Suppl 3:49\u201357","journal-title":"Z Kardiol 91 Suppl"},{"key":"2932_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1475-2840-6-16","volume":"6","author":"Q Zhang","year":"2007","unstructured":"Zhang Q, Lu L, Pu L, Zhang R, Shen J, Zhu Z et al (2007) Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine. Cardiovasc Diabetol 6:16","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2932_CR56","doi-asserted-by":"publisher","first-page":"585","DOI":"10.33549\/physiolres.932106","volume":"60","author":"I Skalsky","year":"2011","unstructured":"Skalsky I, Filova E, Szarszoi O, Parizek M, Lytvynets A, Maluskova J et al (2011) A periadventitial sirolimus-releasing mesh decreased intimal hyperplasia in a rabbit model. Physiol Res 60(3):585\u2013588","journal-title":"Physiol Res"},{"issue":"2","key":"2932_CR57","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jvs.2011.01.047","volume":"54","author":"J Lammer","year":"2011","unstructured":"Lammer J, Bosiers M, Zeller T, Schillinger M, Boone E, Zaugg MJ et al (2011) First clinical trial of Nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive Disease. J Vasc Surg 54(2):394\u2013401","journal-title":"J Vasc Surg"},{"issue":"3","key":"2932_CR58","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/ccd.10034","volume":"55","author":"M Oberhoff","year":"2002","unstructured":"Oberhoff M, Herdeg C, Baumbach A, Karsch KR (2002) Stent-based antirestenotic coatings (sirolimus\/paclitaxel). Catheter Cardiovasc Interv 55(3):404\u2013408","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"2932_CR59","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jacc.2005.09.047","volume":"47","author":"R Wessely","year":"2006","unstructured":"Wessely R, Schomig A, Kastrati A (2006) Sirolimus and Paclitaxel on Polymer-based drug-eluting stents: similar but different. J Am Coll Cardiol 47(4):708\u2013714","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2932_CR60","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1586\/14779072.2016.1112267","volume":"14","author":"E Im","year":"2015","unstructured":"Im E, Hong MK (2015) Drug-eluting stents to prevent stent Thrombosis and restenosis. Expert Rev Cardiovasc Ther 14(1):87\u2013104","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"2932_CR61","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.jvs.2012.04.022","volume":"56","author":"HQ Zhao","year":"2012","unstructured":"Zhao HQ, Nikanorov A, Virmani R, Schwartz LB (2012) Inhibition of experimental neointimal hyperplasia and neoatherosclerosis by local, stent-mediated delivery of everolimus. J Vasc Surg 56(6):1680\u20131688","journal-title":"J Vasc Surg"},{"key":"2932_CR62","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3760\/cma.j.issn.0366-6999.20122864","volume":"126","author":"X Wang","year":"2013","unstructured":"Wang X et al (2013) Oral everolimus inhibits intimal proliferation in injured carotid artery in rats. Chin Med J 126:1906\u20131912","journal-title":"Chin Med J"},{"issue":"10","key":"2932_CR63","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1161\/CIRCULATIONAHA.111.063644","volume":"125","author":"LO Jensen","year":"2012","unstructured":"Jensen LO, Thayssen P, Hansen HS, Christiansen EH, Tilsted HH, Krusell LR et al (2012) Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized trials with clinical outcome IV (SORT OUT IV). Circulation 125(10):1246\u20131255","journal-title":"Circulation"},{"issue":"3","key":"2932_CR64","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1161\/CIRCINTERVENTIONS.113.001322","volume":"7","author":"H Shiomi","year":"2014","unstructured":"Shiomi H, Kozuma K, Morimoto T, Igarashi K, Kadota K, Tanabe K et al (2014) Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: final 3-year follow-up of the Randomized evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial. Circ Cardiovasc Interv 7(3):343\u2013354","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"2932_CR65","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.jcin.2015.03.028","volume":"8","author":"PC Smits","year":"2015","unstructured":"Smits PC, Vlachojannis GJ, McFadden EP, Royaards KJ, Wassing J, Joesoef KS et al (2015) Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and paclitaxel-eluting stents for coronary revascularization in Daily Practice: the COMPARE trial (a trial of Everolimus-Eluting stents and Paclitaxel stents for Coronary Revascularization in Daily Practice). JACC Cardiovasc Interv 8(9):1157\u20131165","journal-title":"JACC Cardiovasc Interv"},{"issue":"23","key":"2932_CR66","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","volume":"125","author":"S Bangalore","year":"2012","unstructured":"Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F et al (2012) Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation 125(23):2873\u20132891","journal-title":"Circulation"},{"issue":"1\u20133","key":"2932_CR67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejphar.2005.09.042","volume":"524","author":"TJ Parry","year":"2005","unstructured":"Parry TJ, Brosius R, Thyagarajan R, Carter D, Argentieri D, Falotico R et al (2005) Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries. Eur J Pharmacol 524(1\u20133):19\u201329","journal-title":"Eur J Pharmacol"},{"issue":"25","key":"2932_CR68","doi-asserted-by":"publisher","first-page":"9463","DOI":"10.1073\/pnas.0400918101","volume":"101","author":"AD Levin","year":"2004","unstructured":"Levin AD, Vukmirovic N, Hwang C-W, Edelman ER (2004) Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. Proc Natl Acad Sci U S A 101(25):9463\u20139467","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11 Suppl","key":"2932_CR69","first-page":"S87","volume":"100","author":"SM Schwartz","year":"1997","unstructured":"Schwartz SM (1997) Smooth muscle migration in Atherosclerosis and restenosis. J Clin Invest 100(11 Suppl):S87\u2013S89","journal-title":"J Clin Invest"},{"issue":"3","key":"2932_CR70","first-page":"880","volume":"6","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zeng Y, Zhu X, Miao L, Liang X, Duan J et al (2021) Significant difference between sirolimus and paclitaxel nanoparticles in anti-proliferation effect in normoxia and hypoxia: the basis of better selection of Atherosclerosis treatment. Bioact Mater 6(3):880\u2013889","journal-title":"Bioact Mater"},{"issue":"14","key":"2932_CR71","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1161\/01.CIR.0000091115.05480.B0","volume":"108","author":"A Farb","year":"2003","unstructured":"Farb A, Burke AP, Kolodgie FD, Virmani R (2003) Pathological mechanisms of fatal late coronary stent Thrombosis in humans. Circulation 108(14):1701\u20131706","journal-title":"Circulation"},{"issue":"6","key":"2932_CR72","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","volume":"109","author":"R Virmani","year":"2004","unstructured":"Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T et al (2004) Localized hypersensitivity and late Coronary Thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109(6):701\u2013705","journal-title":"Circulation"},{"issue":"1","key":"2932_CR73","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jacc.2005.07.071","volume":"47","author":"JR Nebeker","year":"2006","unstructured":"Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J et al (2006) Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the research on adverse drug events and reports (RADAR) project. J Am Coll Cardiol 47(1):175\u2013181","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02932-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-023-02932-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02932-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T16:02:43Z","timestamp":1711296163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-023-02932-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,28]]},"references-count":73,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["2932"],"URL":"https:\/\/doi.org\/10.1007\/s11239-023-02932-5","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,28]]},"assertion":[{"value":"27 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}